There is no doubt whether Feverfew works to relieve the pain and frequency of migraine headaches; numerous published studies show that it does so effectively. The challenge, however, lies with its instability and shortened shelf life. These limtations have prompted many product developers to refrain from utilizing it in migraine formulas. Today, these deficiencies have finally been conquered. OptiPure® is proud to present PharmaFew™, an incredible feverfew extract standardized to contain 3% parthenolides. Amazingly, this product is also the most stable extract with guaranteed 3-year stability— providing an assurance of potency and efficacy. The feverfew found in PharmaFew™ is of the highest quality; it is organically grown in the mineral-rich Galilean farmlands of Israel. The processing takes place in an ISO 9002 and GMP-certified plant. While common feverfew leaf products typically contain up to 0.9% parthenolide and lose stability at a rate of 15% per year, PharmaFew™ surpasses these expectations. A higher-potency product enables formulators to use less of the raw material and leaves rooms for the addition of synergistic ingredients. It also enables consumers to take fewer number of pills, leading to greater compliance and superior results.

Complete Tech Specs